查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1866536

疤痕治疗市场－2025-2030年预测

Scar Treatment Market - Forecasts from 2025 to 2030
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 147 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

预计疤痕治疗市场将从 2025 年的 171.12 亿美元成长到 2030 年的 250.96 亿美元，复合年增长率为 7.96%。

疤痕治疗市场是皮肤科和美容医学领域的重要组成部分，主要针对创伤、手术、烧烫伤、挫伤及其他原因造成的疤痕，这些疤痕会影响皮肤的美观和功能。此市场涵盖的疤痕类型包括瘢痕疙瘩、挛缩性疤痕、增生性疤痕和萎缩性疤痕（主要与挫伤相关），治疗方法包括外用产品、雷射治疗、注射疗法以及新兴的微创治疗方法。随着人们对美观的日益关注和创伤治疗技术的进步，该市场透过线上和线下管道服务于包括医院、诊所和药房在内的各类终端用户。

本报告检验了疤痕治疗市场当前的需求、供应和销售趋势，以及影响该市场发展的最新动态。报告全面分析了关键驱动因素、阻碍因素和机会，并深入探讨了区域产业趋势、政策和法规，使相关人员能够深入了解法规结构和影响市场环境的关键因素。

我们的竞争情报是基于广泛的二手资料研究，旨在识别关键产业参与者及其收入贡献。资讯来源包括产业协会调查、分析师报告、投资者报告、新闻稿和学术期刊。我们采用由下而上和自上而下相结合的方法计算了疤痕治疗行业及其主要细分市场的市场规模。相关数据已透过全球疤痕治疗价值链相关人员的第一手资讯进行检验。我们全面的市场分析整合了多种资讯来源和专有资料集，并运用资料三角验证法，以提供准确的市场区隔和预测。

市场洞察透过分析性叙述、图表和图形呈现，使读者能够有效率地了解全球疤痕治疗市场的趋势。 2024年全球市场规模为292.5亿美元，预计2025年将达322.9亿美元，2034年将达到762亿美元，复合年增长率为10.05%。主要主要企业包括CCA Industries, Inc.、Cynosure, Inc.、Smith & Nephew, Inc.、Sientra, Inc.和Lumenis, Inc.。

主要亮点

由于挫伤疤痕在全球普遍存在，因此已成为主流问题，也带动了对局部治疗的需求。北美凭藉其先进的医疗基础设施处于领先主导，而亚太地区则因人们日益增强的美学意识而增长最快。从治疗类型来看，局部用药占主导地位，硅凝胶等创新技术进一步提升了其疗效。雷射治疗的高成本以及非处方药缺乏实证医学证据，限制了局部用药市场的成长。

成长要素

皮肤损伤（如挫伤和烧烫伤）的日益普遍（每年影响1100万人）推动了市场需求。社群媒体提高了人们对美的认知，并鼓励年轻一代接受美容产品。先进雷射和外用製剂等技术创新正在改善治疗效果。外科手术的增加也导致了术后疤痕管理需求的成长。

抑制因素

雷射疗法等先进治疗方法的高昂费用限制了其在低收入地区的普及，非处方药的临床证据有限削弱了消费者的信心，而熟练的皮肤科医生短缺阻碍了专业治疗方法的广泛应用。

細項分析

依疤痕类型划分：萎缩性（挫伤）疤痕将在2024年占据市场主导地位，市占率达37.9%，这主要归因于其在年轻人中的高发生率。瘢痕疙瘩和增生性疤痕的发生率也在迅速上升，这主要是由于外科手术和烧烫伤病例的增加。

依治疗类型划分：由于价格实惠且使用方便，外用药物预计在2024年将占据60.5%的市场份额。雷射治疗由于能够促进胶原蛋白重塑以改善深层疤痕，预计将呈现最快的增长速度。

按最终用户划分：拥有先进设备的医院占比最大，为 37.2%，而提供专业美容服务的诊所也在快速成长。

按分销管道划分：线上管道正在迅速扩张，从而增加了人们获得非处方药的机会。

区域分析

到2024年，北美将占据38%的市场份额，这得益于其基础设施和创新技术，例如获得FDA批准的雷射技术。亚太地区将以12%的复合年增长率加速成长，主要受中国和印度收入成长以及创伤性损伤病例增加的推动。欧洲将受益于监管支持和人口老化，保持成长动能。

本报告为业内人士提供关于市场趋势、监管环境和竞争动态的关键洞察。报告重点介绍了个人化治疗和微创疗法的机会，同时也探讨了成本效益的挑战。严谨的调查方法结合一手和二手数据，确保了资讯的可靠性，帮助相关人员理解复杂的市场格局，并优先考虑在这一不断发展的领域进行投资，该领域对于美容和功能性皮肤护肤至关重要。

本报告的主要优势：

  • 深入分析：取得以客户群、政府政策和社会经济因素、消费者偏好、垂直产业和其他细分市场为重点的深入市场洞察，涵盖主要地区和新兴地区。
  • 竞争格局：了解主要企业采取的策略倡议，并了解透过正确的策略打入市场的潜力。
  • 市场驱动因素与未来趋势：探索动态因素和关键市场趋势，以及它们将如何塑造未来的市场发展。
  • 可执行的建议：利用洞察力为策略决策提供讯息，从而在动态环境中开拓新的业务管道和收入来源。
  • 受众范围广：对新兴企业、研究机构、顾问公司、中小企业和大型企业都有益处且经济高效。

它是用来做什么的？

产业与市场洞察、商业机会评估、产品需求预测、打入市场策略、地理扩张、资本投资决策、法律规范及影响、新产品开发、竞争影响

分析范围

  • 历史资料（2022-2024 年）和预测资料（2025-2030 年）
  • 成长机会、挑战、供应链前景、法规结构、客户行为和趋势分析
  • 竞争对手定位、策略和市场占有率分析
  • 按业务板块和地区（国家）分類的收入成长和预测分析
  • 公司概况（策略、产品、财务资讯、关键趋势等）

目录

第一章执行摘要

第二章市场概述

  • 市场概览
  • 市场定义
  • 分析范围
  • 市场区隔

第三章 商业情境

  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 波特五力分析
  • 产业价值链分析
  • 政策和法规
  • 策略建议

第四章 技术展望

第五章 按疤痕类型分類的疤痕治疗市场

  • 介绍
  • 瘢痕疙瘩
  • 挛缩性瘢痕
  • 增生性瘢痕
  • 挫伤疤痕
  • 烧烫伤疤痕
  • 术后瘢痕
  • 其他的

第六章 依治疗类型分類的疤痕治疗市场

  • 介绍
  • 硅胶製品
    • 床单
    • 凝胶
  • 外用乳霜和软膏
  • 外科手术和介入治疗
    • 雷射疗法
    • 微针疗法
    • 冷冻疗法
    • 化学换肤
  • 注射
    • 类固醇注射
    • 填料

7. 按最终用户分類的疤痕治疗市场

  • 介绍
  • 医院和诊所
  • 零售
  • 医疗水疗中心

8. 按分销管道分類的疤痕治疗市场

  • 介绍
  • 在线的
  • 离线
    • 医院药房
    • 零售店

9. 按地区分類的疤痕治疗市场

  • 介绍
  • 北美洲
    • 按疤痕类型
    • 按治疗类型
    • 最终用户
    • 透过分销管道
    • 按国家/地区
      • 美国
      • 加拿大
      • 墨西哥
  • 南美洲
    • 按疤痕类型
    • 按治疗类型
    • 最终用户
    • 透过分销管道
    • 按国家/地区
      • 巴西
      • 阿根廷
      • 其他的
  • 欧洲
    • 按疤痕类型
    • 按治疗类型
    • 最终用户
    • 透过分销管道
    • 按国家/地区
      • 英国
      • 德国
      • 法国
      • 义大利
      • 其他的
  • 中东和非洲
    • 按疤痕类型
    • 按治疗类型
    • 最终用户
    • 透过分销管道
    • 按国家/地区
      • 沙乌地阿拉伯
      • 阿拉伯聯合大公国
      • 其他的
  • 亚太地区
    • 按疤痕类型
    • 按治疗类型
    • 最终用户
    • 透过分销管道
    • 按国家/地区
      • 日本
      • 中国
      • 印度
      • 韩国
      • 台湾
      • 其他的

第十章 竞争格局与分析

  • 主要企业和策略分析
  • 市占率分析
  • 企业合併、协议、商业合作
  • 竞争对手仪錶板

第十一章：公司简介

  • CCA Industries, Inc.
  • Cynosure Lutronic
  • Smith & Nephew plc
  • Lumenis
  • Merz Pharma
  • Sonoma Pharmaceuticals, Inc.
  • NewMedical Technology, Inc.
  • Bausch Health Companies Inc.
  • BirchBioMed
  • Perrigo Company plc
  • Stratpharma
  • Molnlycke Health Care AB
  • Alliance Pharma

第十二章调查方法

简介目录
Product Code: KSI061611964

The Scar Treatment Market will surge from USD 17.112 billion in 2025 to USD 25.096 billion by 2030, fueled by a 7.96% compound annual growth rate (CAGR).

The scar treatment market, a vital subset of dermatology and aesthetics, addresses scarring from injuries, surgeries, burns, and conditions like acne, impacting both cosmetic and functional aspects of skin health. This sector encompasses topical products, laser therapies, injectables, and emerging minimally invasive options, catering to scar types including keloids, contractures, hypertrophic, and atrophic (predominantly acne-related). With rising aesthetic awareness and advancements in wound healing, the market supports diverse end-users-hospitals, clinics, pharmacies-via online and offline channels.

This research examines current trends in demand, supply, and sales, alongside recent developments shaping the scar treatment market. It provides a comprehensive analysis of key drivers, restraints, and opportunities. The study details industry trends, policies, and regulations across geographical regions, offering stakeholders a thorough understanding of the regulatory framework and critical factors influencing the market environment.

Competitive intelligence identifies major industry players and their revenue contributions, derived from extensive secondary research. Sources include industry association studies, analyst reports, investor presentations, press releases, and journals. Market size for the overall scar treatment sector and its key segments was determined using both bottom-up and top-down methodologies. Values were validated with primary inputs from stakeholders in the global scar treatment value chain. Comprehensive market engineering integrated data from diverse sources and proprietary datasets, employing data triangulation for accurate market breakdown and forecasting.

Market insights are presented through analytical narratives, charts, and graphics, enabling efficient comprehension of global scar treatment market dynamics. The global market, valued at USD 29.25 billion in 2024, is projected to reach USD 32.29 billion in 2025 and USD 76.20 billion by 2034, growing at a CAGR of 10.05%. Key players profiled include CCA Industries, Inc., Cynosure, Inc., Smith & Nephew plc, Sientra, Inc., and Lumenis, among others.

Key Highlights

Acne scars dominate due to high global prevalence, driving demand for topical treatments. North America leads with advanced healthcare infrastructure; Asia Pacific grows fastest due to rising aesthetic awareness. Topical products lead treatment types; innovations like silicone gels enhance efficacy. High costs of laser therapies and limited OTC evidence restrain growth.

Growth Drivers

Increasing prevalence of skin conditions, including acne and burns affecting 11 million annually, propels demand. Growing aesthetic awareness, amplified by social media, boosts adoption among younger demographics. Technological innovations, such as advanced lasers and topical formulations, improve outcomes. Rising surgical procedures heighten needs for post-operative scar management.

Restraints

High costs of advanced treatments like lasers limit accessibility in low-income regions. Limited clinical evidence for OTC products erodes consumer confidence. Shortage of skilled dermatologists hampers adoption of specialized therapies.

Segmentation Analysis

By Scar Type: Atrophic (acne) scars lead with 37.9% share in 2024, driven by high incidence among youth. Keloids and hypertrophic scars grow rapidly due to surgical and burn cases.

By Treatment Type: Topicals hold 60.5% share in 2024, favored for affordability and ease. Lasers exhibit fastest growth via collagen remodeling for deeper scars.

By End-User: Hospitals dominate at 37.2%, offering advanced infrastructure. Clinics surge with specialized aesthetic services.

By Distribution Channel: Online channels expand rapidly, enhancing access for OTC products.

Regional Analysis

North America commands 38% share in 2024, bolstered by infrastructure and innovations like FDA-cleared lasers. Asia Pacific, at 12% CAGR, accelerates via rising incomes and trauma incidents in China and India. Europe sustains growth through regulatory support and aging populations.

Key Developments

In 2024, Cynosure's PicoSure Pro laser gained FDA clearance for acne scars, enhancing precision. Singapore's A*STAR launched microneedle patches for targeted delivery. Nuance Medical acquired Biocorneum in May 2024, expanding silicone gel offerings.

This report equips industry experts with critical insights into market trends, regulatory landscapes, and competitive dynamics. It highlights opportunities in personalized therapies and minimally invasive options while addressing cost and efficacy challenges. The rigorous methodology, blending primary and secondary data, ensures reliable findings, enabling stakeholders to navigate complexities and prioritize investments in this evolving sector essential to aesthetic and functional skin care.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2022 to 2024 & forecast data from 2025 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Segmentation

By Scar Type

  • Keloid Scars
  • Contracture Scars
  • Hypertrophic Scars
  • Acne Scars
  • Burn Scars
  • Post-Surgical Scars
  • Others

By Treatment Type

  • Silicone-based Products
  • Sheets
  • Gels
  • Topicals Creams & Ointments
  • Surgical & Procedural Treatments
  • Laser Therapy
  • Microneedling
  • Cryotherapy
  • Chemical Peels
  • Injectables
  • Steroid Injections
  • Fillers

By End-User

  • Hospitals & Clinics
  • Retail
  • Medical Spas

By Distribution Channel

  • Online
  • Offline
  • Hospital Pharmacies
  • Retail

By Geography

  • North America
  • United States
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Others
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Taiwan
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. SCAR TREATMENT MARKET BY SCAR TYPE

  • 5.1. Introduction
  • 5.2. Keloid Scars
  • 5.3. Contracture Scars
  • 5.4. Hypertrophic Scars
  • 5.5. Acne Scars
  • 5.6. Burn Scars
  • 5.7. Post-Surgical Scars
  • 5.8. Others

6. SCAR TREATMENT MARKET BY TREATMENT TYPE

  • 6.1. Introduction
  • 6.2. Silicone-based Products
    • 6.2.1. Sheets
    • 6.2.2. Gels
  • 6.3. Topicals Creams & Ointments
  • 6.4. Surgical & Procedural Treatments
    • 6.4.1. Laser Therapy
    • 6.4.2. Microneedling
    • 6.4.3. Cryotherapy
    • 6.4.4. Chemical Peels
  • 6.5. Injectables
    • 6.5.1. Steroid Injections
    • 6.5.2. Fillers

7. SCAR TREATMENT MARKET BY END-USER

  • 7.1. Introduction
  • 7.2. Hospitals & Clinics
  • 7.3. Retail
  • 7.4. Medical Spas

8. SCAR TREATMENT MARKET BY DISTRIBUTION CHANNEL

  • 8.1. Introduction
  • 8.2. Online
  • 8.3. Offline
    • 8.3.1. Hospital Pharmacies
    • 8.3.2. Retail

9. SCAR TREATMENT MARKET BY GEOGRAPHY

  • 9.1. Introduction
  • 9.2. North America
    • 9.2.1. By Scar Type
    • 9.2.2. By Treatment Type
    • 9.2.3. By End-User
    • 9.2.4. By Distribution Channel
    • 9.2.5. By Country
      • 9.2.5.1. United States
      • 9.2.5.2. Canada
      • 9.2.5.3. Mexico
  • 9.3. South America
    • 9.3.1. By Scar Type
    • 9.3.2. By Treatment Type
    • 9.3.3. By End-User
    • 9.3.4. By Distribution Channel
    • 9.3.5. By Country
      • 9.3.5.1. Brazil
      • 9.3.5.2. Argentina
      • 9.3.5.3. Others
  • 9.4. Europe
    • 9.4.1. By Scar Type
    • 9.4.2. By Treatment Type
    • 9.4.3. By End-User
    • 9.4.4. By Distribution Channel
    • 9.4.5. By Country
      • 9.4.5.1. United Kingdom
      • 9.4.5.2. Germany
      • 9.4.5.3. France
      • 9.4.5.4. Italy
      • 9.4.5.5. Others
  • 9.5. Middle East & Africa
    • 9.5.1. By Scar Type
    • 9.5.2. By Treatment Type
    • 9.5.3. By End-User
    • 9.5.4. By Distribution Channel
    • 9.5.5. By Country
      • 9.5.5.1. Saudi Arabia
      • 9.5.5.2. UAE
      • 9.5.5.3. Others
  • 9.6. Asia Pacific
    • 9.6.1. By Scar Type
    • 9.6.2. By Treatment Type
    • 9.6.3. By End-User
    • 9.6.4. By Distribution Channel
    • 9.6.5. By Country
      • 9.6.5.1. Japan
      • 9.6.5.2. China
      • 9.6.5.3. India
      • 9.6.5.4. South Korea
      • 9.6.5.5. Taiwan
      • 9.6.5.6. Others

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 10.1. Major Players and Strategy Analysis
  • 10.2. Market Share Analysis
  • 10.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 10.4. Competitive Dashboard

11. COMPANY PROFILES

  • 11.1. CCA Industries, Inc.
  • 11.2. Cynosure Lutronic
  • 11.3. Smith & Nephew plc
  • 11.4. Lumenis
  • 11.5. Merz Pharma
  • 11.6. Sonoma Pharmaceuticals, Inc.
  • 11.7. NewMedical Technology, Inc.
  • 11.8. Bausch Health Companies Inc.
  • 11.9. BirchBioMed
  • 11.10. Perrigo Company plc
  • 11.11. Stratpharma
  • 11.12. Molnlycke Health Care AB
  • 11.13. Alliance Pharma

12. RESEARCH METHODOLOGY